Collaboration - June 16, 2023
Valo Therapeutics enters research collaboration with Texcell
Valo Therapeutics has announced a collaboration with global contract research organization, Texcell, to investigate immune responses to PeptiCRAd-1 in its Phase 1 clinical study. ValoTx’s PeptiCRAd-1 combines the power of a tumor-specific adenovirus (expressing immune-stimulatory molecules CD40L and OX40L) with immunogenic tumor peptides derived from NY-ESO-1 and MAGE-A3 proteins thereby generating tumor-specific, cytotoxic T-cells that […]
Biotech Business - June 8, 2023
Mendus enters alliance with NorthX and announces a directed share issue
Mendus has entered into a manufacturing alliance with NorthX Biologics and has announced a directed share issue and a fully secured rights issue of units totaling approximately 317 million SEK in financing. In the alliance with NorthX, Mendus and NorthX will co-establish cell therapy manufacturing capabilities in Sweden, which will be used for late-stage development […]
Collaboration - June 5, 2023
Qlucore presents promising results
Qlucore has presented the first results from an EU-funded project for improved diagnosis of lung cancer. The presented results, a new classification model, not only separates different subgroups of primary lung cancer but also indicates whether the tumor sample is a metastasis of breast, colorectal, or kidney cell cancer. This information can have significant implications […]
Collaboration - June 2, 2023
New Swedish COVID-19 biobank sample collection available for research
A national COVID-19 biobank sample collection has been added to the COVID-19 Sample Collection Database, which is available through the Swedish Pandemic Preparedness Portal. This collection includes over 1.5 million samples that are available for use in research. The samples were collated as part of a collaboration between Swedish regional health agencies, the National Pandemic […]
Biotech Business - May 24, 2023
New Swedish innovation cluster for advanced therapies
On behalf of the Swedish government, the Swedish innovation agency Vinnova has decided on funding of an innovation cluster for commercialization, competence development and production capacity for advanced therapies. The new cluster will serve as a national infrastructure and competence node for the benefit of companies throughout the country and it will also strengthen Sweden’s […]
Agreement - May 24, 2023
Novo Nordisk collaborates with Edit Therapeutics
The two companies have announced a research and development collaboration to discover and develop gene editing therapies against a select set of therapeutic targets. With a focus on advancing base editing capabilities, Novo Nordisk will leverage Life Edit’s suite of gene editing technologies to precisely edit the genome with the aim of developing life-changing therapies […]
